Keyphrases
Hepatocellular Carcinoma
94%
Genetic Polymorphism
91%
Ethanol
80%
Pre-microRNA
60%
Hepatic Ischemia-reperfusion Injury
60%
Interleukin-17 (IL-17)
60%
Radiofrequency Ablation
60%
Pancreatic Fluid Collections
60%
Interleukin-6
60%
Odds Ratio
56%
Hepatitis C Virus
55%
GGsTop
50%
Confidence Interval
50%
Polymorphism
47%
Meta-analysis
45%
Rs2275913
43%
Alcoholic Liver Disease
43%
Necrosis
42%
Obesity
38%
High Mobility Group Box 1 (HMGB1)
37%
Therapeutic Effect
36%
Non-alcoholic Fatty Liver Disease (NAFLD)
35%
Glutamyl Transpeptidase
34%
Liver
33%
4-hydroxynonenal (4-HNE)
33%
5′-untranslated Region (5′-UTR)
32%
Ethanol Intake
32%
Japan
31%
Walled-off
31%
Cytochrome P450 2E1 (CYP2E1)
31%
Risk Factors
31%
Limy Bile
30%
Binge Drinking
30%
Simple Steatosis
30%
Image Fusion System
30%
SLC6A4
30%
MicroRNA-325
30%
Functional Dyspepsia
30%
NF1 Gene
30%
Colonic Cancer
30%
Aphthous Stomatitis
30%
Irsogladine Maleate
30%
Recurrent Aphthous Stomatitis
30%
Gastroduodenal Diseases
30%
IL-17F
30%
Nonalcoholic Steatohepatitis
30%
Oxidative Stress
30%
Diabetic Dyslipidemia
30%
Advanced Glycation End Products
30%
Ischemia-reperfusion Injury
30%
Pharmacology, Toxicology and Pharmaceutical Science
Gamma Glutamyltransferase
82%
Ischemia
72%
Nonalcoholic Fatty Liver
60%
Reperfusion Injury
60%
Liver Ischemia
60%
Ethanol
53%
Fatty Liver
52%
Alcohol Liver Disease
46%
Hepatitis C Virus
40%
Alcoholic Fatty Liver
36%
Steatosis
35%
Neoplasm
34%
Therapeutic Effect
33%
Liver Cell Carcinoma
33%
Otsuka Long Evans Tokushima Fatty Rat
33%
1,1 Dimethylhydrazine
30%
Irsogladine Maleate
30%
Aphthous Stomatitis
30%
Duodenum Disease
30%
Dyslipidemia
30%
Recombinant Thrombomodulin
30%
Diabetes Mellitus
30%
Chronic Hepatitis
30%
Osteopontin
30%
Peginterferon
30%
Jejunum Ulcer
30%
Hepatitis C
30%
Advanced Glycation End Product
30%
Delirium
30%
Pancreas Cancer
30%
Ribavirin
30%
Interleukin 6
30%
Liver Fibrosis
30%
Biological Marker
30%
Tissue Injury
30%
Interleukin 17
30%
Colon Carcinoma
30%
4 Hydroxynonenal
29%
Cytochrome
28%
Fibrosis
28%
Adverse Event
25%
Normal Human
17%
Liver Necrosis
11%
Tumor Necrosis Factor
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Acetylsalicylic Acid
10%
Pharmacotherapy
10%
Opiate
10%
Aspartate Aminotransferase
9%
Alanine Aminotransferase
9%
Medicine and Dentistry
Endoscopic Ultrasound
100%
Necrosis
85%
Nonalcoholic Fatty Liver
60%
Hepatocellular Carcinoma
60%
Radiofrequency Ablation
60%
Alcohol Liver Disease
46%
Odds Ratio
39%
Adverse Event
36%
Steatosis
35%
Alcohol
33%
Alcoholic Fatty Liver
33%
Gamma-Glutamyl Transpeptidase
33%
Infection
33%
Therapy Effect
32%
Limy Bile
30%
Thrombocytosis
30%
Diabetes Mellitus
30%
Dyslipidemia
30%
Alcohol Consumption
30%
Oxidative Stress
30%
Pancreas Tumor
30%
Echography
30%
Mesothelioma
30%
Celiac Plexus
30%
Advanced Glycation End-Product
30%
Balloon Dilatation
30%
Pancreas Cancer
30%
Delirium
30%
Chronic Hepatitis
30%
Obstructive Jaundice
30%
Ischemia
30%
Tissue Injury
30%
Fatty Liver
30%
Interleukin 6
30%
Common Bile Duct
25%
4 Hydroxynonenal
25%
Adverse Outcome
22%
Randomized Controlled Trial
20%
Neoplasm
20%
Cytochrome
20%
Common Bile Duct Stone
20%
Endoscopic Retrograde Cholangiopancreatography
20%
Comorbidity
20%
Acute Pancreatitis
17%
Charlson Comorbidity Index
17%
Gastrectomy
16%
Pancreas Pseudocyst
16%
Hepatocyte
15%
Systematic Review
15%
Fine-Needle Aspiration
15%
